LUGPA helps to promote clinical trials to accelerate recruitment process and provide general information on how LUGPA’s independent urology groups can get involved. LUGPA is in no way involved with these trials, but merely providing a resource hub as a service to its members.  

Choose from the following current clinical trials:  

Now Enrolling: LEGEND Phase 2 Sites & Patients LEGEND: A Phase 1/2 study of EG-70 (detalimogene voraplasmid), a novel, investigational, non-viral intravesical gene therapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ (CIS)		Now Enrolling: ORIC-944-01: An Open-Label, Phase 1/1b Study of ORIC-944 as a Single Agent or in Combination with an Androgen Receptor Pathway Inhibitor in Patients with Metastatic Prostate Cancer

Questions? Please contact Kelsey Brooks at [email protected] or (312) 833-3467.